Tag Archive | GSK

GSK says long-acting HIV drug 66% more effective than Truvada

GSK says long-acting HIV drug 66% more effective than Truvada

(Reuters) – Britain’s GSK said on Tuesday that an injection of its cabotegravir drug, given every two months, was found to be 66% more effective in preventing HIV infections than Gilead’s Truvada daily oral pills. HIV incidence rate – or the number of people who contract the infection in a period – was 0.41% with […]